Clean the site with alcohol
Patients with metabolic comorbidities: Autoimmune patients with concurrent insulin resistance, metabolic syndrome, or cardiovascular risk factors benefit doubly, since the GLP-1 addresses both the autoimmune inflammation and the metabolic burden
Tirzepatide follows a similar escalation from 2.5mg up through 5mg, 7.5mg, 10mg, and potentially 12.5mg or 15mg
Estudos iniciais levantaram essa hiptese, mas uma reviso da EMA (2023) concluiu que no h evidncia de relao causal em humanos
The market growth is driven by the increasing prevalence of type 2 diabetes and obesity, rising aging population and lifestyle changes, and ongoing development of new and improved drug formulations
Heart disease, kidney disease, stroke, hypertension, and fatty liver disease often follow in its wake